{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:05:55Z","timestamp":1762103155448,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["PPI-1011"],"award-info":[{"award-number":["PPI-1011"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000263","name":"Parkinson Society Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007867","name":"Universit\u00e9 Laval","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004889","name":"Fondation CHU de Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004889","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.brainres.2019.146460","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T11:10:46Z","timestamp":1568373046000},"page":"146460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Neuroprotection and immunomodulation in the gut of parkinsonian mice with a plasmalogen precursor"],"prefix":"10.1016","volume":"1725","author":[{"given":"Jordan","family":"Nadeau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1702-8910","authenticated-orcid":false,"given":"Tara","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Lamontagne-Proulx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Bourque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Al Sweidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dushmanthi","family":"Jayasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th\u00e9r\u00e8se","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Soulet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2019.146460_b0005","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-012-1040-2","article-title":"Parkinson\u2019s disease is not associated with gastrointestinal myenteric ganglion neuron loss","volume":"124","author":"Annerino","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2019.146460_b0010","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson\u2019s disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2019.146460_b0015","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Beach","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2019.146460_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NRL.0b013e31823d7abb","article-title":"Nonmotor manifestations in Parkinson disease","volume":"18","author":"Bernal-Pacheco","year":"2012","journal-title":"Neurologist"},{"key":"10.1016\/j.brainres.2019.146460_b0025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0161-813X(02)00035-9","article-title":"Pre-treatment with R-lipoic acid alleviates the effects of GSH depletion in PC12 cells: implications for Parkinson\u2019s disease therapy","volume":"23","author":"Bharat","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.brainres.2019.146460_b0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.yfrne.2012.02.003","article-title":"Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson\u2019s disease","volume":"33","author":"Bourque","year":"2012","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.brainres.2019.146460_b0035","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neurobiolaging.2012.05.022","article-title":"Implication of GPER1 in neuroprotection in a mouse model of Parkinson\u2019s disease","volume":"34","author":"Bourque","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2019.146460_b0040","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1096\/fj.07-9677com","article-title":"Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease","volume":"22","author":"Bousquet","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2019.146460_b0045","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2019.146460_b0050","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.bbadis.2012.05.008","article-title":"Functions of plasmalogen lipids in health and disease","volume":"1822","author":"Braverman","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.brainres.2019.146460_b0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2019.146460_b0060","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2019.146460_b0065","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbi.2011.02.017","article-title":"The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity","volume":"25","author":"Cote","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2019.146460_b0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nbd.2015.05.017","article-title":"GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson\u2019s disease","volume":"82","author":"Cote","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2019.146460_b0075","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbi.2015.01.009","article-title":"Partial depletion of the proinflammatory monocyte population is neuroprotective in the myenteric plexus but not in the basal ganglia in a MPTP mouse model of Parkinson\u2019s disease","volume":"46","author":"Cote","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2019.146460_b0080","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.parkreldis.2011.11.025","article-title":"The aging striatal dopamine function","volume":"18","author":"Darbin","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2019.146460_b0085","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","article-title":"Colonic inflammation in Parkinson\u2019s disease","volume":"50","author":"Devos","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2019.146460_b0090","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1515\/CCLM.2009.205","article-title":"Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson\u2019s disease","volume":"47","author":"Dragonas","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.brainres.2019.146460_b0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.disamonth.2007.02.004","article-title":"Autonomic dysfunction in Parkinson\u2019s disease","volume":"53","author":"Dubow","year":"2007","journal-title":"Dis. Mon."},{"key":"10.1016\/j.brainres.2019.146460_b0100","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0022-3565(25)24462-7","article-title":"Dopamine and norepinephrine in the gastrointestinal tract of mice and the effects of neurotoxins","volume":"244","author":"Eaker","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2019.146460_b0105","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2119\/molmed.2011.00119","article-title":"Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson\u2019s disease and incidental Parkinson\u2019s disease","volume":"17","author":"Fabelo","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.brainres.2019.146460_b0110","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/107385840100700308","article-title":"Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia","volume":"7","author":"Farooqui","year":"2001","journal-title":"Neuroscientist"},{"key":"10.1016\/j.brainres.2019.146460_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.brainres.2019.146460_b0120","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/WCO.0000000000000112","article-title":"Premotor and nonmotor features of Parkinson\u2019s disease","volume":"27","author":"Goldman","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.brainres.2019.146460_b0125","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5694\/j.1326-5377.2010.tb03453.x","article-title":"Current concepts in the management of Parkinson disease","volume":"192","author":"Hayes","year":"2010","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.brainres.2019.146460_b0130","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nm1168","article-title":"Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120","volume":"11","author":"Hirasawa","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainres.2019.146460_b0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0165-0270(95)00064-X","article-title":"Cuprolinic blue (quinolinic phthalocyanine) counterstaining of enteric neurons for peroxidase immunocytochemistry","volume":"62","author":"Holst","year":"1995","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.brainres.2019.146460_b0140","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation","volume":"278","author":"Hong","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2019.146460_b0145","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.0000000000001308","article-title":"Parkinson disease with REM sleep behavior disorder: features, alpha-synuclein, and inflammation","volume":"84","author":"Hu","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2019.146460_b0150","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11064-006-9061-7","article-title":"Evidence that plasmalogen is protective against oxidative stress in the rat brain","volume":"31","author":"Kuczynski","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2019.146460_b0155","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nri3088","article-title":"Transcriptional regulation of macrophage polarization: enabling diversity with identity","volume":"11","author":"Lawrence","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.brainres.2019.146460_b0160","first-page":"347","article-title":"Assessment of treatment patterns and patient outcomes in levodopa-induced dyskinesias (ASTROID): a US chart review study","volume":"5","author":"Lennert","year":"2012","journal-title":"Am. Health Drug Benefits"},{"key":"10.1016\/j.brainres.2019.146460_b0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2017.04.004","article-title":"Changes in blood anti-oxidation enzyme levels in MPTP-treated monkeys","volume":"649","author":"Li","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2019.146460_b0170","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1523\/JNEUROSCI.3982-03.2004","article-title":"Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation","volume":"24","author":"Li","year":"2004","journal-title":"J. Neurosci."},{"issue":"Suppl. 12","key":"10.1016\/j.brainres.2019.146460_b0175","first-page":"S308","article-title":"The impact and management of nonmotor symptoms of Parkinson\u2019s disease","volume":"17","author":"Lyons","year":"2011","journal-title":"Am. J. Manage. Care"},{"key":"10.1016\/j.brainres.2019.146460_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151020","article-title":"Plasmalogen augmentation reverses striatal dopamine loss in MPTP mice","volume":"11","author":"Miville-Godbout","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.brainres.2019.146460_b0185","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/BF01291792","article-title":"Interleukin-2 but not basic fibroblast growth factor is elevated in parkinsonian brain. Short communication","volume":"103","author":"Mogi","year":"1996","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.brainres.2019.146460_b0190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.brainres.2010.07.076","article-title":"MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut","volume":"1355","author":"Natale","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2019.146460_b0195","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"issue":"Suppl. 3","key":"10.1016\/j.brainres.2019.146460_b0200","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00415-009-5240-1","article-title":"Non-motor symptoms in Parkinson\u2019s disease","volume":"256","author":"Park","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.brainres.2019.146460_b0205","first-page":"6762528","article-title":"Gastrointestinal dysfunctions in Parkinson\u2019s disease: symptoms and treatments","volume":"2016","author":"Poirier","year":"2016","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.brainres.2019.146460_b0210","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2016.08.004","article-title":"Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson\u2019s disease","volume":"48","author":"Poirier","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2019.146460_b0215","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1111\/j.1365-2982.2012.01887.x","article-title":"A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson\u2019s disease","volume":"24","author":"Pouclet","year":"2012","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.brainres.2019.146460_b0220","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.nbd.2011.08.014","article-title":"A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson\u2019s disease","volume":"45","author":"Pouclet","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2019.146460_b0225","doi-asserted-by":"crossref","first-page":"18","DOI":"10.12968\/hmed.2014.75.1.18","article-title":"Non-motor symptoms: the core of multi-morbid Parkinson\u2019s disease","volume":"75","author":"Sauerbier","year":"2014","journal-title":"Br. J. Hosp. Med. (Lond.)"},{"key":"10.1016\/j.brainres.2019.146460_b0230","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.atc.2006.01.003","article-title":"Novel chemical mediators in the resolution of inflammation: resolvins and protectins","volume":"24","author":"Serhan","year":"2006","journal-title":"Anesthesiol. Clin."},{"key":"10.1016\/j.brainres.2019.146460_b0235","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(95)92707-7","article-title":"Dopaminergic defect of enteric nervous system in Parkinson\u2019s disease patients with chronic constipation","volume":"346","author":"Singaram","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2019.146460_b0240","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomy and subsequent risk of Parkinson\u2019s disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2019.146460_b0245","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0020-1383(79)90006-8","article-title":"The effect of haemorrhage on gastric circulation and acid output in the dog","volume":"10","author":"Szabo","year":"1979","journal-title":"Injury"},{"issue":"Suppl. 1","key":"10.1016\/j.brainres.2019.146460_b0250","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/jnc.13449","article-title":"Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology","volume":"139","author":"Tyson","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2019.146460_b0255","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1476-511X-10-227","article-title":"Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer\u2019s disease","volume":"10","author":"Wood","year":"2011","journal-title":"Lipids Health Dis."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319305141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319305141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:02:57Z","timestamp":1762102977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899319305141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":51,"alternative-id":["S0006899319305141"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2019.146460","relation":{},"ISSN":["0006-8993"],"issn-type":[{"type":"print","value":"0006-8993"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotection and immunomodulation in the gut of parkinsonian mice with a plasmalogen precursor","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2019.146460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"146460"}}